What's breaking now, across thousands of outlets.
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
A garda with severe asthma, withdrawn from a work-from-home arrangement and ordered back on the beat during a winter Covid-19 surge in 2022, was discriminated against - but it is too late to recover…
Multitasking while walking—be it mentally drafting a grocery list or replying to a text message on a phone—is simply second nature to many.
UK health authorities have recorded almost 200 fatalities linked to the anti-obesity medications Mounjaro and Wegovy. These drugs have been associated with more than 150,000 adverse effects.
(MedPage Today) -- The FDA approved the trivalent flu vaccine mRNA-1010 (mFLUSIVA) for use in all adults age 50 years or older, Moderna announced on Wednesday.
Replimune finally has its eureka moment. After two rejections, public clashing with the previous FDA leaders and a closed-door meeting with the White House, the Massachusetts biotech on Thursday…
In this edition of the Nautilus Biotechnology “Proteomics and neuroscience” eBook, we’re excited to dive into tau biology, share what researchers are learning about tau and its role in Alzheimer’s…
